City firm launches anti-fungal drug
The Hindu
Drugmaker SP Accure Labs has launched Amphotericin-B Emulsion, which is indicated for the treatment of Mucormycosis. It is an alternative drug for the fungal infection that is also known as Black Fung
Drugmaker SP Accure Labs has launched Amphotericin-B Emulsion, which is indicated for the treatment of Mucormycosis. It is an alternative drug for the fungal infection that is also known as Black Fungus, a release said. Marketed under the SPAMP-E 50 brand by the Hyderabad-based pharma firm, the MRP of the product is ₹5,400 per injection. An increase in number of people contracting Mucormycosis and the consequent demand for the drugs, used in the treatment, is a challenge the country has been grappling with for some weeks now. The release said Medihauxe Pharma, one of the largest distributors of life-saving drugs in the region, has been exclusively authorised to distribute the drug. “Currently, we have 10,000 vials of the medicine in stock which is sufficient to treat around 1,000 patients,” Medihauxe managing director P.Girish Bhat said.More Related News
Around 440 MBBS graduates of 2021 are not required to undergo one year of compulsory rural service as per the bond signed by them while joining the medical course through government-quota seats in 2015 as the High Court of Karnataka has said the law, enacted in 2012 for mandatory rural service, remained unenforced for 10 years as it was published in the official gazette only in July 2022.